Cybin initiated with a Buy at Guggenheim
PremiumThe FlyCybin initiated with a Buy at Guggenheim
23d ago
Cybin initiated with a Buy at Guggenheim
Premium
The Fly
Cybin initiated with a Buy at Guggenheim
23d ago
Cybin Inc. Reports Q3 2025 Financial Results and Strategic Progress
Premium
Company Announcements
Cybin Inc. Reports Q3 2025 Financial Results and Strategic Progress
24d ago
Cybin price target lowered to $73 from $86 at Canaccord
PremiumThe FlyCybin price target lowered to $73 from $86 at Canaccord
2M ago
Cybin Accelerates PARADIGM Program for Depression Treatment
Premium
Company Announcements
Cybin Accelerates PARADIGM Program for Depression Treatment
2M ago
Psychedelic: Relmada acquires neurosteroid from Asarina
Premium
The Fly
Psychedelic: Relmada acquires neurosteroid from Asarina
2M ago
Cybin Inc. Achieves Breakthroughs in Mental Health Treatment
PremiumCompany AnnouncementsCybin Inc. Achieves Breakthroughs in Mental Health Treatment
3M ago
Cybin files $650M mixed securities shelf
Premium
The Fly
Cybin files $650M mixed securities shelf
3M ago
Cybin Reveals Promising Results in Depression Treatment
Premium
Company Announcements
Cybin Reveals Promising Results in Depression Treatment
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100